Brain Cancer: Epidemiology Forecast to 2027
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem. The type and severity of a brain tumor is defined by the cells from which the tumor originated, as well as by the proliferative potential of the abnormal growth. Only malignant tumors are designated as cancer. Primary brain tumors are those that start in the brain and may, in time, migrate elsewhere in the body, while metastatic brain tumors are those that start elsewhere in the body and migrate to the brain or other parts of the CNS.
GlobalData epidemiologists provide a 10-year epidemiological forecast for the diagnosed incident cases of brain cancer by age and sex, the five-year diagnosed prevalent cases of brain cancer, the diagnosed incident cases of brain cancer by type, and the diagnosed incident cases of brain cancer with associated biomarkers.
In the 8MM, GlobalData epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 119,717 cases in 2017 to 151,067 cases in 2027, at an Annual Growth Rate (AGR) of 2.62%. The five-year diagnosed prevalent cases of brain cancer are also expected to increase from 220,839 cases in 2017 to 262,409 cases in 2027, at an AGR of 1.88% in the same time period.
Scope
The brain cancer Epidemiology Forecast Report and Epidemiology Forecast Model provide an overview of the risk factors and global trends brain cancer in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China).
This report also includes a 10-year epidemiological forecast for the following segmentations in all ages across the 8MM: diagnosed incident cases of brain cancer; five-year diagnosed prevalent cases; diagnosed incident cases of brain cancer type; and diagnosed incident cases of brain cancer with associated biomarkers.
The brain cancer epidemiology forecast report and model were written and developed by Masters- and PhD-level epidemiologists.
The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.
The Epidemiology Forecast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.
Reasons to Buy
The Brain Cancer Epidemiology Forecast series will allow you to:
Develop business strategies by understanding the trends shaping and driving the global brain cancer market.
Quantify patient populations in the global brain cancer market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for brain cancer therapeutics in each of the markets covered.
Understand magnitude of brain cancer population by associated biomarkers.
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.